| Aravind Chandra, | |
|
265 Griffin St E, Amery, WI 54001-1439 | |
| (715) 268-8000 | |
| Not Available |
| Full Name | Aravind Chandra |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 10 Years |
| Location | 265 Griffin St E, Amery, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255742466 | NPI | - | NPPES |
| BP10049445 | Other | TX | BP NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 67829-20 (Wisconsin) | Secondary |
| 207R00000X | Internal Medicine | MD184823 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Vincent Medical Center | Portland, OR | Hospital |
| Providence Portland Medical Center | Portland, OR | Hospital |
| Legacy Mount Hood Medical Center | Gresham, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Legacy Clinics Llc | 0244144004 | 603 |
| Providence Health And Services Oregon | 0648183608 | 1328 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023488343 PECOS PAC ID: 0648183608 Enrollment ID: O20031106000652 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003991845 PECOS PAC ID: 5395656284 Enrollment ID: O20031113000626 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Legacy Clinics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902827272 PECOS PAC ID: 0244144004 Enrollment ID: O20031117000089 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093976243 PECOS PAC ID: 3476450560 Enrollment ID: O20031217000186 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568547503 PECOS PAC ID: 5294623245 Enrollment ID: O20040310000315 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aravind Chandra, Providence Portland Medical Center, 4805 Ne Glisan Street, Portland, OR 97213 Ph: () - | Aravind Chandra, 265 Griffin St E, Amery, WI 54001-1439 Ph: (715) 268-8000 |
News Archive
In many parts of the world, good quality fresh water resources are becoming increasingly scarce. At the same time, wastewater is produced in ever-larger quantities, mainly as a result of the continued growth of the human population and the process of rapid urbanization.
An antibody packaged with a potent chemotherapy drug to selectively destroy acute lymphoblastic leukemia (ALL) cells eradicated or greatly reduced the disease for 61 percent of 46 patients in a phase II study. It will be presented at the 47th annual meeting of the American Society of Clinical Oncology in Chicago June 3-7.
The Penn State team of scientists led by principal investigator Kathleen M. Mulder, Ph.D., professor of pharmacology, and working in conjunction with a researcher from the Center for Cancer Research, National Cancer Institute in Bethesda, Md., studied "km23," a protein that helps to direct protein traffic in the cell.
WHAT: Registered Nurses from the California Nurses Association, activist doctors from the California Physicians Alliance, school employees from the California School Employees Association, and workers and healthcare advocates from the Labor Taskforce on Guaranteed Healthcare will lead a protest Friday at the offices of U.S. Rep. Henry Waxman.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 2 days ago